S.H. Goey

Interferon alfa-2a and interleukin-2 with or without cisplatin in metastatic melanoma: a randomized trial of the European Organization for Research and Treatment of Cancer Melanoma Cooperative Group.

Ulrich Keilholz, S.H. Goey, Cornelis J.A. Punt et al. · Journal of Clinical Oncology · 1997 · 196 citations

Regression of Advanced Ovarian Carcinoma by Intraperitoneal Treatment With Autologous TLymphocytes Retargeted by a Bispecific Monoclonal Antibody

Silvana Canevari, Gerrit Stoter, Flavio Arienti et al. · JNCI Journal of the National Cancer Institute · 1995 · 191 citations

The influence of age and co-morbidity on treatment and prognosis of ovarian cancer: a population-based study

Huub Maas, Roy F.P.M. Kruitwagen, V.E.P.P. Lemmens et al. · Gynecologic Oncology · 2005 · 134 citations

Population-based Study, Cancer Epidemiology, Medicine +11

Adoptive immunotherapy of ovarian carcinoma with bs-MAb-targeted lymphocytes: a multicenter study.

R. L. H. Bolhuis, C. B. H. W. Lamers, S.H. Goey et al. · PubMed · 1992 · 109 citations

Immunocytochemical Technique, Bs-mab-targeted Lymphocytes, Immunology +19

Phase II to III Study Comparing Doxorubicin and Docetaxel With Fluorouracil, Doxorubicin, and Cyclophosphamide As First-Line Chemotherapy in Patients With Metastatic Breast Cancer: Results of a Dutch Community Setting Trial for the Clinical Trial Group of the Comprehensive Cancer Centre

M. Bontenbal, Geert‐Jan Creemers, Hans J. Braun et al. · Journal of Clinical Oncology · 2005 · 102 citations · Full text